Author:
Hung C-F,Tsai Y-C,He L,Coukos G,Fodor I,Qin L,Levitsky H,Wu T-C
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,Molecular Medicine
Reference31 articles.
1. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women [see comments]. Lancet 1992; 339: 1–15.
2. Baum M, Ebb S, Brooks M . Biological fall out from trials of adjuvant tamoxifen in early ovarian cancer. In: Salmon SE (ed). Adjuvant Therapy of Cancer V1. WB Saunders: Philadelphia, 1990, pp 269–274.
3. Swain SM . Selection of therapy for stage III breast cancer. Surg Clin N Am 1990; 70: 1061–1080.
4. Peng KW, TenEyck CJ, Galanis E, Kalli KR, Hartmann LC, Russell SJ . Intraperitoneal therapy of ovarian cancer using an engineered measles virus. Cancer Res 2002; 62: 4656–4662.
5. Shen Y, Nemunaitis J . Fighting cancer with vaccinia virus: teaching new tricks to an old dog. Mol Ther 2005; 11: 180–195.
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献